Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma

Cisplatin is one of the chemotherapeutic drugs used for the management of oral carcinoma, in which combined therapies are estimated to exert superior therapeutic efficacy compared with monotherapy. It is known that poly(ADP-ribosyl)ation is implicated in a multiplicity of cellular activities, such a...

Descripción completa

Detalles Bibliográficos
Autores principales: Paterniti, Irene, Scuderi, Sarah Adriana, Casili, Giovanna, Lanza, Marika, Mare, Marzia, Giuffrida, Raffella, Colarossi, Cristina, Portelli, Marco, Cuzzocrea, Salvatore, Esposito, Emanuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301366/
https://www.ncbi.nlm.nih.gov/pubmed/34356835
http://dx.doi.org/10.3390/biomedicines9070771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301366/
https://www.ncbi.nlm.nih.gov/pubmed/34356835
http://dx.doi.org/10.3390/biomedicines9070771

Ejemplares similares